February 27, 2015 6:05 PM ET


Company Overview of Aragon Pharmaceuticals, Inc.

Executive Profile

David J. Mangelsdorf Ph.D.

Scientific Advisor, Reset Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships


Dr. David J. Mangelsdorf, Ph.D., serves as Scientific Advisor of Reset Therapeutics, Inc. Dr. Mangelsdorf has been a Member of Scientific Advisory Board at Aragon Pharmaceuticals, Inc. since August 2010. Dr. Mangelsdorf served as a Member of the Scientific Advisory Board at Lycera Corporation. Dr. Mangelsdorf serves as the Professor at University of Texas Southwestern Medical Center and Chair of the Department of Pharmacology, and an Investigator of the Howard Hughes ...

Corporate Headquarters

12780 El Camino Real
San Diego, California 92130

United States

Phone: 858-369-7600
Fax: 858-369-7650

Board Members Memberships

There is no Board Members Memberships data available.


PhD 1987
The University of Arizona
BS 1981
Northern Arizona University
Post-Doctoral Training 1993
Salk Institute for Biological Studies

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aragon Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.